Home » Guidance for Industry: Quality Systems Approach to Pharmaceutical CGMP Regulations

Guidance for Industry: Quality Systems Approach to Pharmaceutical CGMP Regulations

You must log in to view this white paper.

Login Now

Not a member yet? Register now.

Overview:

This guidance is intended to help manufacturers implementing modern quality systems and risk management approaches to meet the requirements of the Agency's current good manufacturing practice (CGMP) regulations (2l CFR parts 210 and 211). The guidance describes a comprehensive quality systems (QS) model, highlighting the model's consistency with the CGMP regulatory requirements for manufacturing human and veterinary drugs, including biological drug products.

Author: FDA Center for Drug Evaluation and Reseacb | File Type: PDF

Find more white papers on Process Operations, cGMPs Regulatory Compliance, Facilities Support, Industry Developments

View all white papers »

More content on this topic:

  • Featured White Papers